Dalbavancin compositions for treatment of bacterial infections

Details for Australian Patent Application No. 2005325261 (hide)

Owner Vicuron Pharmaceuticals Inc.

Inventors Stogniew, Martin; Colombo, Luigi; Ciabatti, Romeo

Agent Allens Arthur Robinson

Pub. Number AU-B-2005325261

PCT Pub. Number WO2006/078277

Priority 10/834,395 27.04.04 US

Parent 2003294262

Filing date 26 April 2005

Wipo publication date 27 July 2006

Acceptance publication date 11 November 2010

International Classifications

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

A61K 31/704 (2006.01)

A61K 38/14 (2006.01) Medicinal preparations containing peptides - Peptides containing saccharide radicals

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2006/078277 Priority application(s): WO2006/078277

11 November 2010 Application Accepted

  Published as AU-B-2005325261

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005325262-Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

2005325258-Beta-peptides